LMAT — Lemaitre Vascular Balance Sheet
0.000.00%
- $2.01bn
- $1.83bn
- $219.86m
- 96
- 23
- 78
- 73
Annual balance sheet for Lemaitre Vascular, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 27 | 70 | 82.7 | 105 | 300 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 19.6 | 19.6 | 22 | 25.1 | 30.1 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 94.3 | 140 | 162 | 195 | 402 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 31.1 | 32.1 | 33.5 | 39.8 | 41.6 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 253 | 293 | 310 | 347 | 552 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 25.1 | 21.8 | 25.3 | 29.9 | 30.6 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 80.2 | 38.7 | 42.3 | 48.9 | 215 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 173 | 254 | 268 | 298 | 337 |
| Total Liabilities & Shareholders' Equity | 253 | 293 | 310 | 347 | 552 |
| Total Common Shares Outstanding |